QMS Medical Allied Services, a leading holistic healthcare management solutions company, registered 41.8 per cent growth in net profit on a consolidated basis at Rs 3.46 crore during the quarter ended December 31, 2024, as compared with Rs 2.44 crore same period last year on the back of foray into a new business segment of providing supplies to hospitals.
The company's acquisition of 51 per cent stake in Saarathi Healthcare ‐ a pioneer in patient and disease management services, market access, and phygital solutions earlier this financial year, also helped give a boost to its business.
Operating income on a consolidated basis increased by 24.5 per cent at Rs 44.06 crore during the quarter under review, as against Rs 35.38 crore same period last year. EBITDA increased by 43.1 per cent at Rs 7.14 crore in Q3FY25 as against Rs 4.99 crore last year.
During 9MFY25, consolidated operating income witnessed a growth of 24.3 per cent to Rs 112.06 crore as against Rs 90.18 crore same period last year. Nevertheless, EBITDA declined to Rs 19.66 crore as against Rs 22.91 crore owing to a one‐time marketing expenditure incurred towards business outreach program.
QMS, had earlier forayed into a new business segment of providing hospital supplies and had entered into tie up with various hospitals in Indore, Madhya Pradesh and signed an additional client in Ahmedabad, Gujarat. The company has also been focusing on growing the share of solution‐focused businesses to boost its revenues.
Commenting on the company's performance during the quarter, Mahesh Makhija, Founder, Chairman & Managing Director, QMS Medical Allied Services Limited, said, "Our net profit and total revenues have witnessed a good growth during the third quarter backed by our consistent efforts to ramp up our existing businesses and foray into new segments. We see a huge potential for growth in the hospital supplies business and we are looking to move into newer geographies to tap into the potential of this segment. The acquisition of Saarathi Healthcare, which has managed over 1000 projects and has developed partnerships with over 60 enterprise clients in the last 15 years, has augured well for our company. We have also implemented sustained cost‐reduction strategies which has helped boost our margins."
"We expect the growth momentum to sustain in the coming quarters and our overall performance to witness a robust growth moving forward," he added.
The company's board has approved the Rs 49 crore rights issue subject to regulatory and statutory approvals. QMS plans to use the proceeds from the rights issue to increase its stake in Saarathi Healthcare to 100 per cent going forward.
.jpeg)
